Anteris Technologies

Anteris Technologies is a global structural heart company dedicated to revolutionizing cardiac care. The company focuses on pioneering science-driven advancements in Transcatheter Aortic Valve Replacement (TAVR) technologies, aiming to restore healthy function for heart valve patients. Anteris Technologies is known for developing the world’s first biomimetic TAVR valve, DurAVR® THV, which incorporates proprietary ADAPT® anti-calcification technology to mimic the natural function of a healthy heart valve.